Busca un médico

Alessia Buglioni, M.D.

Publicaciones

  1. Miao J, Thongprayoon C, Krisanapan P, Buglioni A, Craici IM, Cheungpasitporn W. Clinicopathological Characteristics and Kidney Outcomes in Biopsy-Confirmed Acute Interstitial Nephritis. Kidney Int Rep. 2024 Dec; 9 (12):3542-3552 Epub 2024 Oct 10
    View PubMed
  2. Nasr SH, Dasari S, Valeri AM, Theis JD, Moyer A, Buglioni A, Stokes MB, Hasadsri L, Vrana JA, Said SM, Kudose S, Kambham N, Bissonnette ML, Bu L, Gupta R, Suvannasankha A, Martin S, Zeng X, Sothinathan R, Jadoon A, Kebede T, Manickaratnam S, Rosenstock JL, Markowitz GS, Sethi S, Leung N, McPhail ED. Clinicopathologic, Proteomic and Outcome Characteristics of Renal Apolipoprotein C-II Amyloidosis: A Case Series. Am J Kidney Dis. 2024 Nov 13 [Epub ahead of print]
    View PubMed
  3. Wang J, Zhang W, Xu X, Buglioni A, Li P, Chen X, Liu Y, Xu M, Herrick JL, Horna P, Zhang X, Song J, Jevremovic D, He R, Shi M, Yuan J. Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusion. Hum Pathol. 2024 Sep; 151:105626 Epub 2024 July 04
    View PubMed
  4. Buglioni A, Jenkins SM, Nasr SH, Zhang P, Gibson IW, Alexander MP, Herrera Hernandez LP, Fidler ME, Takahashi N, Hogan MC, Cornell LD. Clinicopathologic Features of IgG4-Related Kidney Disease. Kidney Int Rep. 2024 Aug; 9 (8):2462-2473 Epub 2024 May 15
    View PubMed
  5. Denic A, Buglioni A, Turkevi-Nagy S, Mejia MV, Smith BH, Park WD, Subramani R, Kukla A, Diwan TS, Grande JP, Stegall MD. Mesangial Expansion by Morphometry at 5 y After Kidney Transplantation: Incidence, Risk Factors, and Association With Graft Loss. Transplant Direct. 2024 Jul; 10 (7):e1652 Epub 2024 June 13
    View PubMed
  6. Gilani SI, Buglioni A, Cornell LD. IgG4-related kidney disease: Clinicopathologic features, differential diagnosis, and mimics. Semin Diagn Pathol. 2024 Mar; 41 (2):88-94 Epub 2023 Dec 20
    View PubMed
  7. Buglioni A, Guo R, Rumilla KM, Edgar MA, Markovic SN, Zheng G. An Unexpected Diagnosis Uncovered by Quantitative Molecular Findings: A Case Report. J Natl Compr Canc Netw. 2023 Aug; 21 (8):787-791
    View PubMed
  8. Buglioni A, Caffes PL, Hessler MG, Mansfield AS, Lo YC. Clinical Utility Validation of an Automated Ultrarapid Gene Fusion Assay for NSCLC. JTO Clin Res Rep. 2022 Dec; 3 (12):100434 Epub 2022 Nov 09
    View PubMed
  9. Buglioni A, Hasadsri L, Nasr SH, Hogan MC, Moyer AM, Siddique K, Kidd K, Kmoch S, Hodanova K, Bleyer AJ, Alexander MP. Mitochondriopathy Manifesting as Inherited Tubulointerstitial Nephropathy Without Symptomatic Other Organ Involvement. Kidney Int Rep. 2021 Sep; 6 (9):2514-2518 Epub 2021 June 12
    View PubMed
  10. Qin Y, Taylor W, Bamlet WR, Ravindran A, Buglioni A, Cao X, Foote PH, Slettedahl SW, Mahoney DW, Albert PS, Kim S, Hu N, Taylor PR, Etemadi A, Sotoudeh M, Malekzadeh R, Abnet CC, Smyrk TC, Katzka D, Topazian MD, Dawsey SM, Ahlquist D, Kisiel JB, Iyer PG. Methylated DNA Markers of Esophageal Squamous Cancer and Dysplasia: An International Study. Cancer Epidemiol Biomarkers Prev. 2020 Dec; 29 (12):2642-2650 Epub 2020 Sept 18
    View PubMed
  11. Saliba AN, Ferrer A, Gangat N, Pruthi RK, Tefferi A, Higgins A, Bezerra ED, Buglioni A, Salama ME, Klee EW, Pinto E Vairo F, Mangaonkar A, Majerus J, Chen D, Patnaik MM. Aetiology and outcomes of secondary myelofibrosis occurring in the context of inherited platelet disorders: A single institutional study of four patients. Br J Haematol 2020 Sep; 190 (5):e316-e320 Epub 2020 June 22
    View PubMed
  12. Buglioni A, Fidler ME, Alexander MP, Sethi S, Nasr SH, Hernandez LPH, Grande JP, Cosio FG, Cornell LD. De novo pauci-immune glomerulonephritis in renal allografts. Mod Pathol. 2020 Mar; 33 (3):440-447 Epub 2019 Sept 02
    View PubMed
  13. Buglioni A, Wu TT, Mounajjed T. Immunohistochemical and Ultrastructural Features of Hepatocellular Cytoplasmic Globules in Venous Outflow Impairment. Am J Clin Pathol. 2019 Oct 7; 152 (5):563-569
    View PubMed
  14. Cannone V, Buglioni A, Sangaralingham SJ, Scott C, Bailey KR, Rodeheffer R, Redfield MM, Sarzani R, Burnett JC Jr. Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population. Mayo Clin Proc. 2018 Aug; 93 (8):980-990
    View PubMed
  15. Buglioni A, Burnett JC Jr. New Pharmacological Strategies to Increase cGMP. Annu Rev Med. 2016; 67:229-43 Epub 2015 Oct 14
    View PubMed
  16. Buglioni A, Cannone V, Sangaralingham SJ, Heublein DM, Scott CG, Bailey KR, Rodeheffer RJ, Sarzani R, Burnett JC. Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-Up. J Am Heart Assoc. 2015 Dec 23; 4 (12)
    View PubMed
  17. Buglioni A, Burnett JC Jr. Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators. Clin Chim Acta. 2015 Mar 30; 443:3-8 Epub 2014 Oct 23
    View PubMed
  18. Buglioni A, Cannone V, Cataliotti A, Sangaralingham SJ, Heublein DM, Scott CG, Bailey KR, Rodeheffer RJ, Dessi-Fulgheri P, Sarzani R, Burnett JC Jr. Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease. Hypertension. 2015 Jan; 65 (1):45-53 Epub 2014 Nov 03
    View PubMed
  19. Gruson D, Buglioni A, Burnett JC Jr. PTH: Potential role in management of heart failure. Clin Chim Acta. 2014 Jun 10; 433:290-6 Epub 2014 Apr 01
    View PubMed
  20. Sarzani R, Guerra F, Mancinelli L, Buglioni A, Franchi E, Dessi-Fulgheri P. Plasma aldosterone is increased in class 2 and 3 obese essential hypertensive patients despite drug treatment. Am J Hypertens. 2012 Jul; 25 (7):818-26 Epub 2012 May 03
    View PubMed
  21. Guerra F, Mancinelli L, Buglioni A, Pierini V, Rappelli A, Dessi-Fulgheri P, Sarzani R. Microalbuminuria and left ventricular mass in overweight and obese hypertensive patients: role of the metabolic syndrome. High Blood Press Cardiovasc Prev. 2011 Dec 1; 18 (4):195-201
    View PubMed
PST-20299572